[PAR] YoY Annual Result on 30-Jun-2016 [#FY]

Stock
[PAR] Paradigm Biopharmaceuticals Limited
Announcement Date
29-Jun-2016
Financial Year
2016
Quarter
30-Jun-2016 [#FY]
Profit Trend
YoY- -86.84%
Quarter Report
PAR's Result
PAR's Financial Summary
View:
Show?
Annual Result
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 31/03/15 30/06/14 CAGR
Revenue 0 2,984 2,683 1,823 1,291 0 0 -
PBT -15,947 -18,611 -8,873 -6,099 -4,215 -1,565 -231 102.40%
Tax -3,648 -2,984 -2,683 -1,823 -1,291 7 0 -
NP -12,299 -15,628 -6,190 -4,275 -2,924 -1,565 -231 93.84%
Tax Rate - - - - - - - -
Total Cost 12,299 18,611 8,873 6,099 4,215 1,565 231 93.84%
Ratio Analysis
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 31/03/15 30/06/14 CAGR
NP Margin 0.00 -523.73 -230.76 -234.49 -226.60 0.00 0.00 -
Per Share
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 31/03/15 30/06/14 CAGR
EPS -0.06 -0.11 -0.05 -0.04 -0.03 -0.05 0.00 -
EPS Diluted -0.06 -0.11 -0.05 -0.04 -0.03 -0.05 0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.